Cita APA (7a ed.)
Wang, X., Huang, J., Liu, Y., Wu, L., Cai, R., Zheng, Q., & Li, L. (2025). Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma. European Journal of Clinical Pharmacology, 81(3), 383-394.
Cita Chicago Style (17a ed.)
Wang, Xinrui, Jihan Huang, Yixiao Liu, Lijuan Wu, Ruifen Cai, Qingshan Zheng, y Lujin Li. "Quantitative Evaluation of the Efficacy and Safety of First-line Systemic Therapies for Advanced Hepatocellular Carcinoma." European Journal of Clinical Pharmacology 81, no. 3 (2025): 383-394.
Cita MLA (9a ed.)
Wang, Xinrui, et al. "Quantitative Evaluation of the Efficacy and Safety of First-line Systemic Therapies for Advanced Hepatocellular Carcinoma." European Journal of Clinical Pharmacology, vol. 81, no. 3, 2025, pp. 383-394.
Precaución: Estas citas no son 100% exactas.